Revenue FY2025
$6.55B
Net Income
$(0.53B)
EPS (Basic)
$-0.78
Net Margin
-8.1%
ROE
-9.5%
Total Equity
$5.57B
Shares Out
683M
Avantor, Inc. — Laboratory Analytical Instruments. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 10 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Greenhaven Associates
Greenhaven
$0.24B
2.1%
+9.0%
Olstein Capital Management
Robert Olstein
$0.01B
1.7%
+47.9%
Prescott General Partners
Prescott General Partners
$0.03B
1.5%
—
Southeastern Asset Management
Mason Hawkins
$0.05B
1.3%
+34.2%
Yacktman Asset Management
Yacktman
$0.05B
0.4%
+0.5%
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$0.10B
0.3%
(3.5%)
Royce & Associates
Royce & Associates
$0.04B
0.3%
+151.2%
Dodge & Cox
Dodge & Cox
$1.19B
0.3%
+0.3%
First Pacific Advisors
FPA
$0.08B
0.3%
+1.3%
Bridgewater Associates
Bridgewater Associates
$0.00B
0.0%
+134.9%
Insider Transactions
Reading stored insider transactions…